221 filings
Page 8 of 12
CT ORDER
ljhsa66obk8vhsy eq7
29 Aug 18
Confidential treatment order
12:00am
8-K
qzkabmwzlei58t94b to
20 Aug 18
Athenex Appoints Randoll Sze as Chief Financial Officer
12:00am
8-K
2skghy6r8y
17 Aug 18
Athenex Pharma Solutions, an Athenex, Inc. Company, Launches Compounded Vasopressin Injection inReady-to-Use Premix IV Bags
4:59pm
8-K
4jpqigxg
14 Aug 18
Athenex, Inc. Announces Second Quarter 2018 Results and Provides Corporate Update
7:00am
D
v63bqpt06kia41lxx
17 Jul 18
$50M in equity / options, sold $50M, 1 investor
4:43pm
8-K
qlkk94 8yqy7xppnu
2 Jul 18
Athenex Announces Pipeline Expansion Initiatives in Conjunction with a Strategic Investment of $100 million by Perceptive Advisors
4:06pm
8-K
blctvx rb
15 Jun 18
Athenex Announces Appointment to Board of Directors
4:16pm
8-K
zjjjh4ey fukyx14e
14 Jun 18
Submission of Matters to a Vote of Security Holders
12:00am
8-K
928xfp 9lzt5xe29
14 May 18
Athenex, Inc. Announces First Quarter 2018 Results
8:02am
DEFA14A
v8zel qd7jdny8bsc6p
30 Apr 18
Additional proxy soliciting materials
7:09am
DEF 14A
u30guub
30 Apr 18
Definitive proxy
7:04am
8-K
umi6mn
30 Apr 18
Athenex, Inc. Announces Transition of James Zukin from
6:50am
8-K
97oz5awqneit
26 Mar 18
Athenex, Inc. Announces Fourth Quarter and Full-Year 2017 Results
12:00am
10-K
8v0vn
26 Mar 18
Annual report
12:00am
8-K
6lpigmfzyh
16 Mar 18
Departure of Directors or Certain Officers
12:00am
424B4
kl9xz3
25 Jan 18
Prospectus supplement with pricing info
12:00am
EFFECT
se9i4
24 Jan 18
Notice of effectiveness
12:00am